Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

RU58841 pre-mixed solution loses effectiveness after two weeks. Users suggest mixing RU58841 powder with ethanol and PG instead of Minoxidil for better results.

The conversation discusses a hair loss treatment protocol involving minoxidil, finasteride, ketoconazole shampoo, and RU58841. The user reports success with this regimen, particularly noting RU58841's effectiveness in regrowing hair without side effects.

A 24-year-old shares 5.5 months of hair regrowth progress using topical and oral minoxidil, finasteride, and Nizoral shampoo. They experienced initial shedding but saw improvement after 3.5 months and recommend starting treatment early.

The user has been using Alpecin and Nizoral, which improved hair texture and reduced shedding and itching. They are hesitant to use finasteride or minoxidil and are seeking other suggestions to slow hair loss and improve hair appearance.

A user started finasteride and zinc for hair loss, planning to add ketoconazole. They hope this combination will be effective.

The conversation discusses the safety and use of ketoconazole shampoo for hair loss, with mentions of zinc pyrithione and selenium sulfide. Users debate the safety of these ingredients, particularly zinc pyrithione, and share opinions on regulatory differences between Europe and the US.

The user shared before and after photos showing hair regrowth after one month of using a combination of 6% minoxidil, 0.05% finasteride, 0.05% jxl069, 5% RU58841, and Nizoral shampoo. Another user noted progress and suggested using a scope to monitor further changes.

People are discussing the use of an untested hair loss treatment called PP405, which is not available on the grey market. Some users are trying a mimic formulation called HP3, reporting thicker hair but no new growth yet.

A new hair loss treatment, pp405, may regrow hair better than finasteride and minoxidil, with potential availability by 2028. However, there is skepticism about its effectiveness and commercialization timeline.

Pelage Pharmaceuticals is starting Phase 3 trials for PP405 in September 2026, with potential market release by 2030. Users discuss various hair loss treatments like minoxidil, finasteride, RU58841, kx, breezula, and gt20029, expressing hope for future hair restoration.

A user applied the 8T3 product for hair loss, targeting LPP and AGA, and plans to update on its effectiveness. The product uses a saline buffered phosphate vehicle, suitable for those intolerant to ethanolic vehicles.

Using a face serum with 1% copper peptides (ghk-cu) on the scalp as an adjunct to finasteride and minoxidil for hair growth and scalp health. The user is unable to find a specific hair serum with ghk-cu locally.

OP noticed fuller and thicker hair after almost 4 months of using GHK-Cu, a copper-binding peptide, through subcutaneous injections. Some users were skeptical, questioning the authenticity and potential commercial intent behind the post.

Kx-826 at 0.5% shows limited effectiveness for hair loss, while 1% is more promising but expensive. RU58841 is considered a more feasible option until 1% kx-826 becomes affordable.

The user has been mixing finasteride with stemoxydine for hair loss and is considering switching to a less expensive product with a different ingredient list. They are questioning if the new product's higher water content compared to alcohol will affect the finasteride's solubility.

The user is using 1mg oral finasteride daily, applying topical minoxidil 1-2 times daily, and using Nizoral shampoo twice a week for hair regrowth. They are discussing their progress at month 13 of this treatment regimen.

Pelage is moving to Phase III clinical trials for PP405, a hair loss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.

The conversation is about a person using dutasteride and minoxidil for hair loss, considering adding RU58841 and PP405 for more density. They are seeking advice on using these treatments and exploring other options like GT20029.

The user reported positive results in hair density and skin improvement using a combination of oral Minoxidil, Finasteride, and subcutaneous GHK-Cu. They experienced less shedding with oral Minoxidil compared to topical and noted significant skin benefits from GHK-Cu.

The user is using topical finasteride 0.1%, minoxidil 5% twice daily, red light therapy, a multi-peptide serum, and a weekly oil hair mask with various oils and ingredients. They also use ketoconazole shampoo, condition their hair, and microneedle with a dermapen, seeking advice on any changes to their routine.

The user reports noticeable hair growth after 5 weeks using finasteride, minoxidil, dermarolling, and ketoconazole. They seek confirmation of their progress and question if they are a hyper responder.

The conversation is about finding an alternative ketoconazole shampoo to Nizoral due to its strong smell, with suggestions including Intelligent shampoo and Sons brand. The discussion also touches on the effectiveness of ketoconazole for dandruff and hair loss, with some users recommending prescription options for higher concentrations.

The conversation discusses using RU58841 for hair loss, with OP applying a 5% premixed solution from Receptorchem daily. Users express skepticism about the rapid results and inquire about other treatments and costs.

PP405 is a new hair loss treatment that may outperform minoxidil and finasteride by growing thick hair in bald areas within four weeks. Its release is expected around 2028, but concerns about its long-term efficacy and cost remain.

The user is seeking advice for temple hair recovery, using 2% minoxidil, dermarolling, nutrient patches, and green clay compresses, but is hesitant to use finasteride. Others suggest increasing minoxidil to 5%, using finasteride or RU58841, and incorporating ketoconazole shampoo to address hair loss effectively.

The user is experiencing an allergic reaction to propylene glycol in Kirkland minoxidil and is considering switching to a foam version or a low-PG minoxidil solution. They are also contemplating oral minoxidil but are concerned about its long-term safety.

PP405 is discussed as a potential alternative to finasteride, but its effectiveness and market availability are uncertain. Users share experiences with finasteride, minoxidil, and topical treatments, noting side effects and application techniques.

PP405 is considered a potential new treatment for hair loss, compared to finasteride and minoxidil. There is skepticism about its effectiveness in humans, with anticipation for more information from an upcoming conference.

The conversation is about hair loss treatment progress using 2.5mg oral Minoxidil daily, derma rolling weekly, and Ketoconazole shampoo thrice weekly, with plans to add oral Dutasteride. Users discuss the potential benefits and timing of using Dutasteride for hair recovery.

People are discussing the anticipated release of PP405 phase 2a results, expected by the end of March, with some skepticism about its effectiveness. There is cautious optimism due to past experiences with similar treatments like Breezula, despite concerns about the lack of presentation at the AAD 2026 conference.